DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Aesthetic Treatment Market Analysis by Procedure, by End use, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The non-invasive aesthetic treatment market size is estimated to be USD 55.3 billion in 2021 and is expected to witness a CAGR of 17.25% during the forecast period 2022-2029.
The increased focus on physical looks among adults, growing influence of social media are some of the key drivers for the market growth.
Additionally, rising healthcare infrastructure in developing economies is projected to drive the market growth in near future. However, high cost of treatment process and post therapeutic issues are expected to restrain the market growth.
Segmentation: Non-Invasive Aesthetic Treatment Market Report 2021-2029
By Procedure (Revenue, USD Billion)
- Skin Rejuvenation
- Injectables
- Others
By End use (Revenue, USD Billion)
- Med Spa
- Hospital/ Surgery Centre
- HCP Owned Clinic
- Traditional Spa
By Region (Revenue, USD Billion)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Companies Mentioned
- Allergan-AbbVie (US)
- Alma Lasers Ltd. (Israel)
- Anika Therapeutics (US)
- Cutera Inc. (US)
- Cynosure (US)
- El.En. S.p.A. (Italy)
- Fotona d.o.o. (Slovenia)
- Galderma (Switzerland)
- Johnson & Johnson (US)
- Merz Pharma GmbH & Co. KGaA (Germany)
- Medytox Inc. (South Korea)
For more information about this report visit https://www.researchandmarkets.com/r/ons04z
